专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US08158620B2 Fused aminodihydrothiazine derivatives 有权
标题翻译：融合氨基二氢噻嗪衍生物
公开(公告)号：US08158620B2
公开(公告)日：2012-04-17
申请号：US12355154
申请日：2009-01-16
申请人： Yuichi Suzuki , Takafumi Motoki , Toshihiko Kaneko , Mamoru Takaishi , Tasuku Ishida , Kunitoshi Takeda , Yoichi Kita , Noboru Yamamoto , Afzal Khan , Paschalis Dimopoulos
发明人： Yuichi Suzuki , Takafumi Motoki , Toshihiko Kaneko , Mamoru Takaishi , Tasuku Ishida , Kunitoshi Takeda , Yoichi Kita , Noboru Yamamoto , Afzal Khan , Paschalis Dimopoulos
IPC分类号： C07D513/02 , C07D279/08 , A61K31/542
CPC分类号： A61K31/542 , C07D279/08 , C07D417/10 , C07D417/12 , C07D417/14 , C07D471/04 , C07D513/04
摘要： A compound represented by the general formula: or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein Ring A is a C6-14 aryl group or the like, L is —NReCO— or the like (wherein Re is a hydrogen atom or the like), Ring B is a C6-14 aryl group or the like, X is a C1-3 alkylene group or the like, Y is a single bond or the like, Z is a C1-3 alkylene group or the like, R1 and R2 are each independently a hydrogen atom or the like, and R3, R4, R5 and R6 are independently a hydrogen atom, a halogen atom or the like, has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia.
摘要翻译：由通式表示的化合物或其药学上可接受的盐或其溶剂化物，其中环A是C 6-14芳基等，L是-NReCO-等（其中Re是氢原子或环）B是C 6-14芳基等，X是C 1-3亚烷基等，Y是单键等，Z是C 1-3亚烷基等，R 1 和R 2各自独立地为氢原子等，R 3，R 4，R 5和R 6独立地为氢原子，卤素原子等，具有A＆bgr; 产生抑制作用或BACE1抑制作用，可用作由A＆Bgr引起的神经变性疾病的预防或治疗剂; 并以阿尔茨海默氏型痴呆为代表。

12. 发明申请

US20080227815A1 Crystal of Indole Derivative Having Piperidine Ring and Process for Production Thereof 审中-公开
标题翻译：具有哌啶环的吲哚衍生物的晶体及其制备方法
公开(公告)号：US20080227815A1
公开(公告)日：2008-09-18
申请号：US11913931
申请日：2006-05-11
申请人： Takahisa Sakaguchi , Yuichi Suzuki , Koichi Ito , Jun Niijima , Mamoru Miyazawa , Toshikazu Shimizu , Masaharu Gotoda , Naoko Suzuki , Takashi Hasebe
发明人： Takahisa Sakaguchi , Yuichi Suzuki , Koichi Ito , Jun Niijima , Mamoru Miyazawa , Toshikazu Shimizu , Masaharu Gotoda , Naoko Suzuki , Takashi Hasebe
IPC分类号： A61K31/454 , C07D405/14 , A61P25/18 , A61P25/30
CPC分类号： C07D405/14
摘要： A crystal of 1-[1-[2-(7-methoxy-2,2-dimethyl-4-oxochroman-8-yl)-ethyl]piperidin-4-yl]-N-methyl-1H-indole-6-carboxamide fumarate which has peaks at chemical shifts of about 124.0 ppm and about 26.8 ppm in a 13C solid NMR spectrum.
摘要翻译： 1- [1- [2-（7-甲氧基-2,2-二甲基-4-氧代色满-8-基） - 乙基]哌啶-4-基] -N-甲基-1H-吲哚-6- 富马酸甲酰胺，在13 C固体NMR光谱中具有约124.0ppm和约26.8ppm的化学位移的峰。

13. 发明申请

US20070219179A1 Indole Derivative Having Piperidine Ring 失效
标题翻译：具有哌啶环的吲哚衍生物
公开(公告)号：US20070219179A1
公开(公告)日：2007-09-20
申请号：US11579903
申请日：2005-05-11
申请人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Miyuki Sakai , Hiroshi Ishihara , Atsuhiko Kubota
发明人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Miyuki Sakai , Hiroshi Ishihara , Atsuhiko Kubota
IPC分类号： A61K31/454 , A61K31/4725 , A61K31/536 , A61K31/553 , A61P13/02 , A61P13/10 , A61P43/00 , C07D401/04 , C07D405/14 , C07D413/14 , C07D417/14
CPC分类号： C07D491/08 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14
摘要： The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical: wherein R1 and R2 are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R3 represents a hydrogen atom or the like; and R6 represents a hydrogen atom or the like. This compound has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor, and is useful as an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage.
摘要翻译：本发明涉及由下式表示的化合物，其药理学上可接受的盐或其作为药物的用途：其中R 1和R 2是相邻的取代基并且与它们各自连接的两个碳原子一起形成5-至7-元非芳族碳环基等，其可以被1至4个选自以下的取代基取代：（1）氧代基团，（2）羟基等; R 3表示氢原子等; R 6表示氢原子等。该化合物与5-HT 1A受体的结合强度优异，对受体具有拮抗作用，可用作治疗或预防下尿路症状的药剂，特别是有关尿液储存的症状。

14. 发明授权

US07538123B2 Indole derivative having piperidine ring 失效
标题翻译：具有哌啶环的吲哚衍生物
公开(公告)号：US07538123B2
公开(公告)日：2009-05-26
申请号：US11579903
申请日：2005-05-11
申请人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Miyuki Sakai , Hiroki Ishihara , Atsuhiko Kubota
发明人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Miyuki Sakai , Hiroki Ishihara , Atsuhiko Kubota
IPC分类号： A61K31/454
CPC分类号： C07D491/08 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14
摘要： The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical: wherein R1 and R2 are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R3 represents a hydrogen atom or the like; and R6 represents a hydrogen atom or the like. This compound has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor, and is useful as an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage.
摘要翻译：本发明涉及由下式表示的化合物，其药理学可接受的盐或其作为药物的用途：其中R 1和R 2是彼此相邻的取代基，并且与它们各自连接的两个碳原子一起形成可被1〜4个选自（1）氧代基，（2）羟基等的取代基取代的5〜7元非芳族碳环基等。 R3表示氢原子等; R6表示氢原子等。该化合物与5-HT 1A受体的结合强度优异，对受体具有拮抗作用，可用作治疗或预防下尿路症状的药剂，特别是有关尿液储存的症状。

15. 发明申请

US20080119518A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives 审中-公开
标题翻译： 1-（哌啶-4-基）-1H-吲哚衍生物
公开(公告)号：US20080119518A1
公开(公告)日：2008-05-22
申请号：US11795923
申请日：2006-02-02
申请人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Daisuke Shinmyo , Miyuki Sakai , Hiroki Ishihara , Atsuhiko Kubota
发明人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Daisuke Shinmyo , Miyuki Sakai , Hiroki Ishihara , Atsuhiko Kubota
IPC分类号： A61K31/4545 , A61K31/454 , C07D403/14
CPC分类号： C07D401/04 , C07D401/14
摘要： The present invention provides a compound represented by the formula (1) or a pharmacologically acceptable salt thereof, or a hydrate thereof (provided that a compound in which all of R4a, R4b, and R4c are hydrogen atoms is excluded.): [wherein R1 represents a hydrogen atom, R2 represents a hydrogen atom, R3 represents the formula: wherein R4a, R4b, and R4c are the same as or different from each other and each represents a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, etc.]
摘要翻译：本发明提供由式（1）表示的化合物或其药理学上可接受的盐或其水合物（不包括其中R4a，R4b和R4c全部为氢原子的化合物。）：[其中R 1 表示氢原子，R2表示氢原子，R3表示下式：其中R4a，R4b和R4c彼此相同或不同，各自表示氢原子，C 1-6 >烷基或C 1-6烷氧基等]

16. 发明申请

US20050256103A1 Indole derivative having piperidine ring 审中-公开
标题翻译：具有哌啶环的吲哚衍生物
公开(公告)号：US20050256103A1
公开(公告)日：2005-11-17
申请号：US11126209
申请日：2005-05-11
申请人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Miyuki Sakai , Hiroki Ishihara , Atsuhiko Kubota
发明人： Yuichi Suzuki , Koichi Ito , Atsushi Sasaki , Koshi Ueno , Miyuki Sakai , Hiroki Ishihara , Atsuhiko Kubota
IPC分类号： A61K31/454 , A61K31/4725 , A61K31/536 , A61K31/55 , A61K31/553 , A61P13/02 , A61P13/10 , A61P43/00 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D491/08 , C07D41/14 , C07D43/14
CPC分类号： C07D491/08 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14
摘要： The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical: wherein R1 and R2 are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R3 represents a hydrogen atom or the like; and R6 represents a hydrogen atom or the like. It is an object of the present invention to discover an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage, which has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor.
摘要翻译：本发明涉及由下式表示的化合物，其药理学上可接受的盐或其作为药物的用途：其中R 1和R 2是相邻的取代基并且与它们各自连接的两个碳原子一起形成5-至7-元非芳族碳环基等，其可以被1至4个选自以下的取代基取代：（1）氧代基团，（2）羟基等; R 3表示氢原子等; R 6表示氢原子等。本发明的目的是发现用于治疗或预防下尿路症状的药剂，特别是关于尿液储存的症状，其具有优于5-HT 1A受体的结合强度和对受体的拮抗作用。

17. 发明授权

US09072631B2 Absorbent article with leaking-prevention units having elastic members 有权
标题翻译：具有防弹单元的吸收制品具有弹性构件
公开(公告)号：US09072631B2
公开(公告)日：2015-07-07
申请号：US13321423
申请日：2010-05-17
申请人： Osamu Nakajima , Yuichi Suzuki , Yuki Noda
发明人： Osamu Nakajima , Yuichi Suzuki , Yuki Noda
IPC分类号： A61F13/15 , A61F13/20 , A61F13/475 , A61F13/472 , A61F13/515 , A61F13/494
CPC分类号： A61F13/4753 , A61F13/15723 , A61F13/15739 , A61F13/15756 , A61F13/47263 , A61F13/4942 , A61F13/515
摘要： A leakage-preventing unit 50 of an absorbent article 1 is formed by elastic members 51 and sheets 52. The leakage-preventing unit 50 includes a central region C and a pair of end unit regions S positioned outside a longitudinal direction L from the central region C.The elastic members 51 includesa fixed unit 51A fixed to the sheet 52 in a state when the elastic members 51 extend in the longitudinal direction L and a free end 51B positioned outside the longitudinal direction L from the fixed unit 51A, which is not fixed to the sheet 52. The end unit regions S includes a joint processing unit 53A in which a joint process for joining the portions where the sheets 52 face each other is performed and a non-joint processing unit 53B in which the joint process is not performed. The free end 51B is arranged in the non-joint processing unit 53B.
摘要翻译：吸收性物品1的防漏单元50由弹性构件51和片52形成。防漏单元50包括中心区域C和位于从中心区域的纵向方向L外侧的一对端部单元区域S 弹性构件51包括固定单元51A，该固定单元51A在弹性构件51沿长度方向L延伸的状态下固定到片材52，而固定单元51A从固定单元51A位于长度方向L外侧的自由端51B 端部单元区域S包括接合处理单元53A，其中进行用于连接片材52彼此面对的部分的接合处理和非接合处理单元53B，其中接合处理不是执行。自由端51B布置在非联合处理单元53B中。

18. 发明授权

US08744223B2 Array-type photo module 有权
标题翻译：阵列型照片模块
公开(公告)号：US08744223B2
公开(公告)日：2014-06-03
申请号：US13410131
申请日：2012-03-01
申请人： Yuto Yamashita , Keiichi Sasaki , Etsuo Ogino , Yasuaki Tamura , Yuji Akahori , Yuichi Suzuki
发明人： Yuto Yamashita , Keiichi Sasaki , Etsuo Ogino , Yasuaki Tamura , Yuji Akahori , Yuichi Suzuki
IPC分类号： G02B6/32
CPC分类号： G02B6/425 , G02B6/4215
摘要： The present invention provides an array-type photo module including a filter, which, in each channel, transmits therethrough a portion of emitted light from an incident optical fiber on the opposite side of a gradient-index lens array and reflects another portion of the emitted light from the incident optical fiber toward the gradient-index lens array, and a light-shielding member which is arranged on the opposite side of the filter from the gradient-index lens array, so as to be spaced from the filter and, in each channel, has an opening passing therethrough transmitted light from the filter on the opposite side of the filter. The array-type photo module is easily and inexpensively manufactured, and may be used in a high-density array, with low crosstalk.
摘要翻译：本发明提供了一种阵列型照相模块，它包括一个滤光器，它在每个通道中透过其中一部分来自入射光纤的发射光，在入射光纤位于相反的一个梯度折射率透镜阵列上，从入射光纤到达梯度折射率透镜阵列的光;以及遮光构件，其设置在与滤光镜相反的一侧，与滤光镜相隔离，并且每个通道具有穿过过滤器相对侧上的来自过滤器的透射光的开口。阵列型光模块容易且廉价地制造，并且可以以低串扰的高密度阵列使用。

19. 发明授权

US08545111B2 Optical module 有权
标题翻译：光模块
公开(公告)号：US08545111B2
公开(公告)日：2013-10-01
申请号：US12666583
申请日：2008-06-30
申请人： Takaharu Ohyama , Yoshiyuki Doi , Ikuo Ogawa , Akimasa Kaneko , Yasuaki Tamura , Yuichi Suzuki
发明人： Takaharu Ohyama , Yoshiyuki Doi , Ikuo Ogawa , Akimasa Kaneko , Yasuaki Tamura , Yuichi Suzuki
IPC分类号： G02B6/36
CPC分类号： G02B6/42 , G02B6/12019 , G02B6/30 , G02B6/4201 , G02B6/4267 , G02B6/4268 , G02B6/4281 , G02B6/4283 , H01L2224/48091 , H01S5/02208 , H01S5/02248 , H01S5/02284 , H01L2924/00014
摘要： An optical module has a structure for reducing the stress applied to a package. The optical module is structured so that an end face of a waveguide (37) of a planar lightwave circuit (30) is joined to a plurality of packages (40) storing therein optical elements so that the waveguide is optically coupled to the optical elements. The optical module includes a housing (3) storing therein a planar lightwave circuit and a plurality of packages in which an upper face of a protrusion (270) formed in the bottom section is fixed to the planar lightwave circuit (30). Each of the plurality of packages (40) is electrically connected to an electric part (22) provided in the housing (3) via flexible printed circuits (271a, 271b).
摘要翻译：光学模块具有用于减小施加到包装上的应力的结构。光学模块被构造成使得平面光波电路（30）的波导（37）的端面与存储有光学元件的多个封装（40）接合，使得波导光耦合到光学元件。光学模块包括容纳有平面光波电路的壳体（3）和形成在底部的突起（270）的上表面固定在平面光波回路（30）上的多个封装体。所述多个封装体（40）中的每一个通过柔性印刷电路（271a，271b）电连接到设置在所述壳体（3）中的电气部件（22）。

20. 发明授权

US08274574B2 Imaging apparatus for outputting an image signal according to a set shooting mode 有权
标题翻译：用于根据设定的拍摄模式输出图像信号的成像装置
公开(公告)号：US08274574B2
公开(公告)日：2012-09-25
申请号：US12139141
申请日：2008-06-13
申请人： Yuichi Suzuki
发明人： Yuichi Suzuki
IPC分类号： H04N5/225 , H04N3/14 , H04N5/335
CPC分类号： H04N5/232 , H04N5/23245 , H04N5/343 , H04N5/3456 , H04N5/347 , H04N2101/00
摘要： An imaging apparatus having as a shooting mode a normal shooting mode and a continuous shooting mode for generating a plurality of pieces of image data, includes a setting unit operable to set a shooting mode, an imaging element having as a read mode a normal read mode for outputting image signals of all pixels and a mixing read mode for mixing and outputting an image signal of a predetermined pixel and image signals of peripheral pixels of the predetermined pixel, and a pixel mixing controller operable to control the read mode of the imaging element. The pixel mixing controller controls the imaging element to operate in the mixing read mode when the shooting mode is set to the continuous shooting mode.
摘要翻译：具有用于产生多张图像数据的正常拍摄模式和连续拍摄模式的拍摄模式的成像装置包括可设置拍摄模式的设置单元，具有作为读取模式的正常读取模式的成像元件用于输出所有像素的图像信号和用于混合和输出预定像素的图像信号的混合读取模式和预定像素的外围像素的图像信号的像素混合控制器，以及可操作以控制成像元件的读取模式的像素混合控制器。当拍摄模式设置为连拍模式时，像素混合控制器控制成像元件在混合读取模式下操作。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式